First candidate from Tenvie’s product engine to enter clinical developmentPhase 1 first-in-human study to evaluate single and multiple ascending doses of TNV262 in healthy volunteers and persons with ...

Phase 1 clinical trial will evaluate the safety, tolerability, and pharmacokineticsSBS-147 is a novel and potent oral ...

First-in-class TET2 activator targets DNA damage response in GBM and other cancersStrong preclinical efficacy, brain penetration, and safety profile support clinical advancementStudy led by ...

Nurix Therapeutics, Inc. has announced a webcast conference call scheduled for June 12, 2025, at 8:00 a.m. ET to discuss new data from its ongoing Phase 1 clinical trial of bexobrutideg (NX-5948), ...

John Mascarenhas, MD, discusses the rationale, mechanism, and design of the phase 1 INCA33989-101 and -102 trials investigating a CAL-R–targeted antibody for patients with essential thrombocythemia.

The MarketWatch News Department was not involved in the creation of this content. KTX-2001 being evaluated both as a monotherapy and in combination with darolutamide in metastatic castration-resistant ...

Rationale and study design of the KOV-HIPEC-02R (RECOVER): A randomized, multicenter, open-label phase III trial of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ...

AI would identify new drug targets, generate molecules, and compress years of chemistry into weeks. Those promises were not ...

HOUSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. (MBRX), (“Moleculin” or the “Company”), today announced positive results from the Emory University physician-sponsored Phase 1 ...

Clinical trials are studies that test new medical interventions, such as a new type of drug, surgery, or medical device, on human volunteers. They aim to determine whether the new treatment option is ...